Defining the Secondary Window: 24 Hours to 12 Weeks Postpartum
Postpartum hemorrhage is divided into two clinical entities. Primary PPH occurs within the first 24 hours after delivery and is the form managed by the obstetric team — uterine atony, retained placenta, lacerations, and coagulopathy account for the majority. Secondary PPH (also called late PPH or delayed PPH) is bleeding that occurs from 24 hours after delivery through 12 weeks postpartum, and the responsible person at that point is no longer the L&D team — it is the mother herself, perhaps a partner, with telephone access to a clinician who may or may not respond promptly.
ACOG's Practice Bulletin 183 ('Postpartum Hemorrhage') and the WHO postpartum care recommendations both flag secondary PPH as under-recognized. Population data place its incidence at 0.5-2% of vaginal deliveries and slightly higher after cesarean. The peak window is days 7-14 postpartum, but cases occur from day 2 through week 6 routinely. By 6 weeks, most postpartum bleeding has resolved; bleeding that begins de novo or recurs after this point is unusual and warrants evaluation.
The most common etiologies of secondary PPH are: retained products of conception (residual placental fragments, 30-40% of cases), uterine subinvolution (the uterus failing to shrink back, 20-30%), endometritis (uterine infection, often coexists with retained products), abnormal placentation (placenta accreta spectrum disorders), inherited bleeding disorders (von Willebrand, sometimes diagnosed only after PPH), and rare causes like cesarean scar dehiscence and arteriovenous malformations. Cesarean delivery raises secondary PPH risk slightly, as does primary PPH at the index delivery.
Lochia Normal vs Lochia Concerning: A Field Guide
Lochia is the normal postpartum vaginal discharge, and its evolution is predictable. Lochia rubra is bright red, lasts approximately days 1-4, and may contain small clots. Lochia serosa is pink-brown, lasts approximately days 5-10, and is sparser. Lochia alba is yellow-white, lasts from day 10 through weeks 4-6, and tapers gradually. A small amount of intermittent bleeding through week 6 is normal, especially with breastfeeding letdown or increased activity.
Departures from this pattern that warrant clinical evaluation: bleeding that intensifies rather than tapers (lochia should consistently decrease, not increase), return of bright red bleeding after lochia has progressed to brown or white, soaking through more than one maxi-pad per hour for two consecutive hours, passage of any clot larger than an egg or golf ball, a sudden gush of blood that drenches clothing, foul-smelling discharge with fever or pelvic pain (endometritis), or persistent lochia rubra past day 5.
Quantification matters. Subjective 'heavy bleeding' is unreliable; clinicians and patients alike consistently underestimate blood loss. ACOG recommends parents track pad saturation — a fully saturated overnight or maxi pad holds approximately 60-90 mL. Saturating more than one pad per hour for two hours is approximately 120-180 mL/hour or more, which is at or above the ACOG threshold for evaluation. If a postpartum mother is changing pads more often than she expected, the answer is to count, not to guess.
A practical home-care plan worth establishing before discharge: a written pad-count rubric, the OB office phone number and after-hours number both saved in the partner's phone, the nearest ED address, and an agreement about who calls and what triggers a call. This 10-minute conversation prevents many secondary PPH cases from becoming emergencies.
Retained Products of Conception: The Most Common Driver
Retained products of conception (RPOC) are residual placental fragments, membranes, or decidual tissue remaining in the uterus after delivery. They are the single most common cause of secondary PPH, responsible for an estimated 30-40% of cases. The clinical presentation is typically delayed-onset, increasing bleeding — often around day 7-10 postpartum — sometimes preceded by a relatively normal early postpartum course. Pelvic cramping and fever may accompany the bleeding, particularly if RPOC has triggered superimposed endometritis.
Diagnosis is by transvaginal ultrasound, which identifies an intrauterine echogenic mass or thickened endometrial stripe (over 10 mm with vascular flow on Doppler is suspicious). Beta-hCG may be elevated, though it can also be persistently elevated for benign reasons in the early postpartum period. The differential includes blood clot (which can mimic RPOC on ultrasound), uterine subinvolution alone, and endometritis without retained products.
Treatment depends on severity and the patient's clinical stability. For mild bleeding without infection, expectant management with close follow-up can be appropriate — small fragments may pass spontaneously. For moderate to severe bleeding, or for cases with concomitant infection, suction dilation and curettage (D&C) is the definitive treatment, often combined with IV antibiotics if endometritis is suspected. In selected stable patients, medical management with misoprostol (a uterotonic) has been studied with mixed results and is most useful when surgery is not immediately available.
The single highest-yield action a postpartum mother can take if she suspects RPOC is to call her OB the same day and request a same-week ultrasound. Waiting for a routine 6-week postpartum visit when bleeding has changed character is a recurring pattern in maternal morbidity reviews. The condition is treatable; the delay is the danger.
Uterine Subinvolution, Endometritis, and the Cesarean-Specific Risks
After delivery, the uterus undergoes involution — a process of muscular contraction and tissue remodeling that shrinks the uterus from approximately 1,000 g at delivery to 50-100 g by 6 weeks postpartum. When this process is incomplete (uterine subinvolution), the uterus remains larger, the placental site vessels remain incompletely thrombosed, and persistent or recurrent bleeding can result. Subinvolution is diagnosed by bimanual exam (uterus larger and softer than expected for the postpartum interval) and ultrasound. Treatment is uterotonic medication (methylergonovine, oral misoprostol) and observation; underlying drivers (retained products, infection, fibroids) should be ruled out.
Endometritis is uterine inflammation, almost always infectious in the postpartum context. The presentation classically includes fever at or above 100.4 F, foul-smelling lochia, lower abdominal/pelvic pain, and uterine tenderness; bleeding may be heavier than expected. Risk factors include cesarean delivery (especially after labor), prolonged rupture of membranes, multiple cervical exams, and retained products. Treatment is intravenous broad-spectrum antibiotics (typically gentamicin + clindamycin) until 24-48 hours afebrile, followed by completion of an oral course. Most cases resolve fully with appropriate treatment, but delayed care can progress to pelvic abscess or sepsis.
Cesarean delivery introduces additional risk pathways. Cesarean scar dehiscence (separation of the uterine incision) can present with delayed bleeding 1-3 weeks postpartum and may require surgical repair. Placenta accreta spectrum (PAS) disorders, increasingly common with rising cesarean rates, can present at delivery or during the early postpartum period with abnormal bleeding when a residual accreta fragment was not removed. A history of any prior cesarean delivery, any prior PPH, or any prior uterine surgery should raise the threshold for early ultrasound evaluation when secondary PPH is suspected.
Beyond uterine causes, inherited bleeding disorders — particularly von Willebrand disease, affecting approximately 1% of women — are sometimes first identified by an episode of postpartum hemorrhage. Any woman with a history of menorrhagia, easy bruising, or bleeding with prior dental work who experiences secondary PPH should have a coagulation workup including vWF antigen, vWF ristocetin cofactor activity, and factor VIII.
The Action Plan: What to Do at Home, When to Call, When to Go
Stage 1 — at home, monitoring. Any postpartum mother experiencing a change in lochia pattern (return of bright red, increase in volume, new clots) but who is hemodynamically stable should: lie down with legs slightly elevated, hydrate orally, take her temperature, count pads over the next hour, and call her OB office. A clear, written log — what time bleeding started, pad saturation level, presence/size of clots, associated symptoms — is the single most useful thing to bring to a phone triage or ED visit.
Stage 2 — call the OB now. Trigger: saturating one maxi-pad in 1 hour or less, passing clots larger than an egg, bleeding accompanied by fever at or above 100.4 F or foul-smelling discharge, persistent pelvic pain not relieved by ibuprofen, or any return of fresh bleeding more than 14 days postpartum after lochia had clearly resolved. An OB office should triage this in real time and either bring the patient in same-day for ultrasound or direct to ED.
Stage 3 — go to the ED. Trigger: saturating one maxi-pad in less than 30 minutes for more than 2 hours, gushing or fountain-like bleeding, signs of hemodynamic compromise (dizziness on standing, palpitations, shortness of breath, pallor, cold clammy skin), confusion or near-syncope, severe pelvic pain, or any bleeding the patient feels is 'different and frightening' from her postpartum baseline. Do not wait for a callback. Severe PPH can progress rapidly; transfusion may be needed.
Recovery, if treatment is timely, is excellent. Most secondary PPH cases resolve with same-day evaluation and treatment of the underlying cause. The majority of women return to normal cycles and full health within 8-12 weeks. The maternal morbidity that follows secondary PPH is almost entirely a function of how long the bleeding was allowed to continue before evaluation — making earliness the single most modifiable variable, and the one fully in patient and family control.
The cultural framing of postpartum care in the US — a single 6-week visit, often delayed because of the demands of a newborn at home — is exactly mismatched to the time-course of secondary PPH risk, which peaks at week 1-2. ACOG, AWHONN, and WHO have all advocated for restructuring postpartum care toward earlier and more frequent contact, including a 1-2 week postpartum visit (in-person or telehealth) specifically aimed at catching bleeding pattern abnormalities, mood symptoms, and early lactation concerns before they become crises. Patients and partners do not need to wait for systemic change to apply this framework at the household level: pre-arrange a 1-week pediatric visit for the baby, ask the OB office for a 2-week postpartum check-in, and treat any deviation from expected lochia trajectory as a 'call now' event rather than a 'mention at the next appointment' event.
Documentation matters more than memory. A simple postpartum bleeding log — date, time, pad saturation level, clot description, associated symptoms — kept on a phone notes app and shared with the OB at any concerning moment is the artifact that turns subjective worry into actionable triage. Most secondary PPH cases reviewed in maternal morbidity audits cited a 'change a few days ago' that was not reported promptly because it didn't feel acute enough; a written log eliminates that pattern.